Electronic cigarette aerosol particle size distribution measurements
Non-Clinical
Respiratory Toxicity
Ingebrethsen (2012)
assessing the mutagenic activities of smoke from different cigarettes in direct exposure experiments using the modified ames Salmonella assay
Non-Clinical
Respiratory Toxicity
Ishikawa (2016)
a systems toxicology approach for comparative assessment: Biological impact of an aerosol from a candidate modified-risk tobacco product and cigarette smoke on human organotypic bronchial epithelial cultures
Non-Clinical
Respiratory Toxicity
Iskandar (2017)
a lower impact of an acute exposure to electronic cigarette aerosols than to cigarette smoke in human organotypic buccal and small airway cultures was demonstrated using systems toxicology assessment.
Nonclinical
Respiratory Toxicity
In Vitro
Iskandar (2019)
Secondhand nicotine vaping at home and respiratory symptoms in young adults.
Individual Clinical
Respiratory Toxicity
Secondary & Tertiary Exposure
Islam (2022)
In vitro long-term repeated exposure and exposure switching of a novel tobacco vapor product in a human organotypic culture of bronchial epithelial cells.
Nonclinical
Respiratory Toxicity
In Vitro
Ito (2020)
Mainstream smoke Constituents and In Vitro toxicity comparative analysis of 3R4F and 1R6F reference cigarettes
Non-Clinical
Respiratory Toxicity
In Vitro
Jaccard et al (2019)
Firsthand and Secondhand Exposure Levels of Maltol-Flavored Electronic Nicotine Delivery System Vapors Disrupt amino acid Metabolism.
Individual Clinical
Respiratory Toxicity
Jarrell (2021)
Evaluation of In vitro assays for assessing the Toxicity of Cigarette Smoke and Smokeless Tobacco
Non-Clinical
Respiratory Toxicity
In Vitro
Johnson (2009)
Impact of vaping on respiratory health.
Individual Clinical
Respiratory Toxicity
Relative Health Effects Of User
Jonas (2022)